Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Scientific Session

Spondyloarthritis (SpA) including psoriatic arthritis (PsA)
General Topic: Clinical Science

12S114: Pearls & Pitfalls in Diagnosing Non-Radiographic Axial Spondyloarthritis

Sunday, November 12, 2023
9:00 AM – 10:00 AM PT
Location: Room 29A-D
CE: 1

In Person On Demand

    Speaker(s)

  • Lianne Gensler, MD

    Professor of Medicine
    University of California San Francisco
    San Francisco, CA, United States

    Disclosure(s): AbbVie: Advisor or Review Panel Member (Terminated), Consultant (Terminated); Acelyrin: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Eli Lilly: Consultant (Terminated); Fresenius Kabi: Advisor or Review Panel Member (Terminated); Janssen: Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing)

  • MH

    Mark Hwang, MD, MS

    McGovern Medical School at the University of Texas Health Science Center at Houston
    Houston, TX, TX, United States

    Disclosure(s): Jannsen: Grant/Research Support (Ongoing); UCB BIopharma: Consultant (Ongoing)

  • Alexis Ogdie, MD

    Rheumatologist, Associate Professor of Medicine
    University of Pennsylvania
    Philadelphia, PA, United States

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Celgene: Consultant (Ongoing); CorEvitas: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Gilead: Consultant (Ongoing); GSK: Consultant (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing), Grant/Research Support (Ongoing); Pfizer: Consultant (Ongoing), Grant/Research Support (Ongoing); Takeda: Consultant (Ongoing); UCB: Consultant (Ongoing)

This session will review the diagnostic approach to nonradiographic axial spondyloarthritis, with an emphasis on the role of imaging and recognition of its mimics.

Learning Objectives:

  • Review the diagnostic approach to nonradiographic axial spondyloarthritis.
  • Discuss the role of imaging in diagnosing nonradiographic axial spondyloarthritis.
  • Recognize the mimics of nonradiographic axial spondyloarthritis.

Presentations:

  • 9:00 AM – 9:15 AM PT
    Diagnostic Approach to Non-Radiographic Axial Spondyloarthritis

    Speaker: Mark Hwang, MD, MS – McGovern Medical School at the University of Texas Health Science Center at Houston

  • 9:15 AM – 9:30 AM PT
    The Role of Imaging for Non-Radiographic Axial Spondyloarthritis

    Speaker: Lianne S. Gensler, MD – University of California San Francisco

  • 9:30 AM – 9:45 AM PT
    Recognizing the Mimics of Axial Spondyloarthritis

    Speaker: Alexis Ogdie, MD – University of Pennsylvania

  • 9:45 AM – 10:00 AM PT
    Q&A